Work

The pathophysiology of paroxysmal nocturnal haemoglobinuria

Year: 2014
Type: dissertation
Study design: Observational Study
Abstract: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life-threatening condition caused \nby an expansion of a clone of haemopoietic stem cells (HSC) harboring a somatic \nmutation of the PIG-A gene. PNH blood cells are deficient in glycophosphatidylinositollinked \n(GPI) proteins rendering PNH erythrocytes susceptible to complement attack \nwhich leads to intravascular haemolysis and an increased tendency to develop \nthromboses. \nThe survival of 79 consecutive patients treated with eculizumab was compared to both \nage and sex matched normal controls and to 30 similar patients managed in the era \nimmediately prior to anti-complement therapy. The survival of those treated with \neculizumab was no different that of the control group and was significantly better than \nthe group with PNH that did not receive eculizumab (p=0.3). Transfusion requirements \nand documented thromboses were reduced with eculizumab. Sixty-six percent of \ntransfusion dependent patients became transfusion independent and thrombotic events \nreduced from 5.6 to 0.8 events per 100 years. \nEleven women were monitored through 15 pregnancies whilst on eculizumab. There was \n1 first trimester miscarriage and 15 healthy babies born. There were no maternal deaths \nobserved and no thrombotic events occurred in the pregnancy or the postpartum period. \nEculizumab did not appear to cross the placenta or be expressed in breast milk. \nThirty-five patients were evaluated for PIG-M mutations to see if this mutation was \nprevalent in PNH. No PIG-M promoter mutations were identified. Two genes were \nevaluated to see if secondary mutations affecting them could account for clonal \nexpansion in PNH. Thirty-six patients underwent JAK2 V617F mutation analysis with 1 \npatient shown to have a JAK2 mutation. Forty-two patients were evaluated for increased \nHMGA2 levels by 2 different PCR methods. There was an overall reduction in HMGA2 \nexpression in PNH patients as compared to normal controls. \nAn in vitro model of the bone marrow in PNH was developed and 18 PNH bone marrow \nsamples were evaluated using this model. Colony forming assays (CFA) showed an \nincrease in colony formation when T-cells were removed from the PNH bone marrow \nsamples. This improvement was reversed when the T-cells were added back to the \nexperiments. This work supports an immune mechanism for the expansion of the PNH \nclone.
Institution: University of Leeds
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W1529367789
Cites: 322
Cited by: 1
Related to: 10